Growing Clinical Evidence:
11 Countries And 39 Investigators
8 Studies
> 800 Patients
≤ 4% TLR
6 to 18 months follow up
Low thrombosis rates (Max reported rate 0,3%)
Overview
click image to enlarge
Clinical publications

Six-Month Clinical Follow-Up of the Tryton Side Branch Stent for the
Treatment of Bifurcation Lesions: A Two Center Registry Analysis

Michael Magro, MD, Joanna Wykrzykowska, MD, Patrick W. Serruys, MD, PhD,
Cihan Simsek, MD, Sjoerd Nauta, MSc, Maciej Lesiak, MD, PhD,
Katarzyna Stanislawska, MSc, Yoshinobu Onuma, MD,
Evelyn Regar, MD, PhD, Ron T. van Domburg, PhD,
Stefan Grajek, MD, PhD, and Robert-Jan Van Geuns, MD, PhD
Download PDF

Intravascular Ultrasound Evaluation of Complex Bifurcation Lesions Treated
with Tryton Side Branch Stent in Conjunction with Everolimus-Eluting Stents.

ACC 2009. Centro Cardiologico Monzino, IRCCS, University of Milan, Milan – Italy.
D. Trabattoni, MD, FACC; F. Fabbiocchi, MD; P. Montorsi, MD; S. Galli, MD;
P. Ravagnani, MD; A. Lualdi, MD; L. Grancini, MD;  A.L. Bartorelli, MD, FACC
Download PDF

Assessment with optical coherence tomography of a new strategy for bifurcational lesion treatment: The Tryton Side-Branch Stent
Wiley-Liss
Download PDF

Tryon I, First-In-Man Study: Six Month Clinical & Angiograpic Results
EuroIntervention
Download PDF

Tryton I, First-In-Man Study: Acute and 30-day Outcome
EuroIntervention
Download PDF

    The Tryton Side Branch Stent System™ is currently not available for commercialization in the USA.
COMPANY | PRODUCT | CLINICAL | DISTRIBUTORS | NEWS & EVENTS | CAREERS | CONTACT
TRYTON I | CLINICAL PRESNTATIONS